Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alon Eisen

Showing results (1-10 of 102) with videos related to

Pageof 11
Sort By:
Journal of Thoracic Disease|July 20, 2018
Early treatment with high-potency statins in patients with acute coronary syndrome-an example of personalized medicineEmanuel Harari, Alon Eisen
Expert Review of Cardiovascular Therapy|August 7, 2020
Aspirin and low-dose rivaroxaban - the dual pathway concept in patients with stable atherosclerotic disease: a comprehensive reviewEliot Parascandolo, Alon Eisen
Current Opinion in Cardiology|September 24, 2016
Advances in the field of proprotein convertase subtilisin kexin type 9 inhibitorsAlon Eisen, Robert P Giugliano
Nature Reviews. Cardiology|June 10, 2015
Antiplatelet therapy: Defining the optimal duration of DAPT after PCI with DESAlon Eisen, Deepak L Bhatt
Cardiology in Review|July 18, 2015
Antiplatelet and Anticoagulation Treatment in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome: Comparison of the Updated North American and European GuidelinesAlon Eisen, Robert P Giugliano
Heart (British Cardiac Society)|November 27, 2016
Optimal duration of dual antiplatelet therapy after acute coronary syndromes and coronary stentingAlon Eisen, Deepak L Bhatt
Diabetes/Metabolism Research and Reviews|March 5, 2017
Novel oral anticoagulants (NOACs) in patients with atrial fibrillation (AF) and diabetes-Good or excellent?Aviv A Shaul, Alon Eisen
Therapeutic Advances in Cardiovascular Disease|December 19, 2015
Edoxaban in patients with atrial fibrillationAlon Eisen, Christian T Ruff
Kardiologia Polska|February 5, 2023
A novel approach to post-acute myocardial infarction careAvital Porter, Alon Eisen, Mark Kheifets
Harefuah|March 25, 2008
[Ischemic preconditioning of the heart]Alon Eisen, Ehud Schwammenthal, Yehuda Adler
Pageof 11

Showing results (1-10 of 102) with videos related to

Sort By:
Pageof 11
Journal of Thoracic Disease|July 20, 2018
Early treatment with high-potency statins in patients with acute coronary syndrome-an example of personalized medicineEmanuel Harari, Alon Eisen
Expert Review of Cardiovascular Therapy|August 7, 2020
Aspirin and low-dose rivaroxaban - the dual pathway concept in patients with stable atherosclerotic disease: a comprehensive reviewEliot Parascandolo, Alon Eisen
Current Opinion in Cardiology|September 24, 2016
Advances in the field of proprotein convertase subtilisin kexin type 9 inhibitorsAlon Eisen, Robert P Giugliano
Nature Reviews. Cardiology|June 10, 2015
Antiplatelet therapy: Defining the optimal duration of DAPT after PCI with DESAlon Eisen, Deepak L Bhatt
Cardiology in Review|July 18, 2015
Antiplatelet and Anticoagulation Treatment in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome: Comparison of the Updated North American and European GuidelinesAlon Eisen, Robert P Giugliano
Heart (British Cardiac Society)|November 27, 2016
Optimal duration of dual antiplatelet therapy after acute coronary syndromes and coronary stentingAlon Eisen, Deepak L Bhatt
Diabetes/Metabolism Research and Reviews|March 5, 2017
Novel oral anticoagulants (NOACs) in patients with atrial fibrillation (AF) and diabetes-Good or excellent?Aviv A Shaul, Alon Eisen
Therapeutic Advances in Cardiovascular Disease|December 19, 2015
Edoxaban in patients with atrial fibrillationAlon Eisen, Christian T Ruff
Kardiologia Polska|February 5, 2023
A novel approach to post-acute myocardial infarction careAvital Porter, Alon Eisen, Mark Kheifets
Harefuah|March 25, 2008
[Ischemic preconditioning of the heart]Alon Eisen, Ehud Schwammenthal, Yehuda Adler
Pageof 11